Medanta Gurgaon’s Brain Pacemaker Surgery Restores Hope, Offers Second Chance at Life to J&K Patients
Srinagar, Apr 04: Medanta– The Medicity in Gurugram, ranked the best hospital in India by Newsweek in 2026, is an internationally known destination for Deep Brain Stimulation (DBS) therapy, also known as ‘Brain-Pacemaker surgery’. This cutting-edge neurostimulation procedure, spearheaded by Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, employs advanced imaging techniques for precise brain targeting and utilizes state-of-the-art innovations such as real-time brain-sensing biomarker feedback for symptom-responsive stimulation.
Explaining the procedure, Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, said, “DBS or Brain Pacemaker Surgery is a transformative therapy wherein electrodes are implanted in specific affected areas of the brain to regulate abnormal signals, restoring motor function, and greatly enhancing quality of life. It is known to bring relief to advanced-stage symptoms of Parkinson’s disease, dystonia, epilepsy (adult onset), essential tremor, and obsessive-compulsive disorder (OCD).”
This technology uses tiny implanted electrodes to read brain signals and understand how the brain is functioning. By correlating these signals with a patient’s symptoms, doctors gain clear, measurable insights that help fine-tune DBS therapy more precisely, resulting in better and more consistent symptom control over time.
Highlighting the growing burden of neurological disorders in India, Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, said, “Neurological conditions are among the leading causes of disability worldwide and account for nearly 10% of our country’s total disease burden. While advanced treatments like DBS can significantly improve patient outcomes, access to such therapies remains a key challenge.”
Despite the availability of effective treatments, awareness and access remain limited. At Medanta, DBS therapy has already transformed the lives of hundreds of patients, including Jammu resident Mrs. Harmeet Kour and Mr. Gandharv Chand from Udhampur.
Parkinson’s had also significantly impacted Mrs. Kour’s daily life, making even simple tasks difficult, such as holding a cup. By the time she consulted Dr. Banerjee, her condition had progressed to an advanced stage. The 60-year-old shared, “After undergoing brain pacemaker surgery, my symptoms improved dramatically. With regular device tuning, my condition is now well managed, and the care I received has truly changed my life.”
Mr. Chand, meanwhile, witnessed a significant improvement in his symptoms following DBS surgery, with his tremors resolving. This allowed him to regain independence and confidence in everyday activities that had earlier been difficult. The procedure proved transformative, greatly enhancing his quality of life and empowering him to manage his daily routine with renewed assurance.
With over 300 successful DBS procedures performed over the past 15 years, Dr. Banerjee is widely regarded as a leading expert in this field. Medanta’s DBS program integrates advanced technologies such as AI-guided brain targeting and remote programming, enabling more precise treatment and continuous care. These innovations are particularly beneficial for patients from smaller cities like Srinagar and Jammu, as they reduce the need for frequent travel to Metros for follow-up care.
Dr. Banerjee said, “In addition, we have also launched AI-guided Adaptive DBS, which monitors brain activity and automatically adjusts treatment in real time, reducing the need for frequent doctor-led reprogramming sessions that were earlier required.”
About Global Health Limited (Medanta):
Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest civilian awards in India, and the Dr. B.C. Roy Award in recognition of his distinguished contribution to medicine.
Global Health Limited (the “Company”) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited.
Under the “Medanta” brand, the Company has a network of six hospitals currently in operation (Gurgaon, Indore, Ranchi, Lucknow, Patna and Noida). Spanning an area of 5.6 million sq. ft., its operational hospitals have 3,579 installed beds as on December 31, 2025. It also has four upcoming hospitals in Mumbai, Pitampura – New Delhi, South Delhi and Guwahati. The Company provides healthcare services in over 30 medical specialties and engages over 2,300+ doctors led by highly experienced department heads.
